Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05666778Phase 2Active Not Recruiting

Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs

Role: collaborator

NCT06468462Phase 4Recruiting

Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM

Role: collaborator

NCT03223532Not ApplicableCompleted

Randomized Trial Comparing PrePex Day 7 Foreskin Removal Procedure (FRP) to a Day 0 PrePex FRP .

Role: lead

NCT02277795Not ApplicableCompleted

Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya

Role: collaborator

NCT01711411Completed

Observational Study of Male Circumcision Using PrePex Device

Role: collaborator

All 5 trials loaded